References
- 1. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803-820.10.1007/s00401-016-1545-127157931
- 2. Ostrom QT, Gittleman H, Xu J, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol. 2016;18(suppl_5):v1-v75.10.1093/neuonc/now207848356928475809
- 3. Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. 2017;19:270-280.
- 4. Ostrom QT, Rubin JB, Lathia JD, et al. Females have the survival advantage in glioblastoma. Neuro Oncol. 2018;20:576-577.10.1093/neuonc/noy002590962529474647
- 5. Grech N, Dalli T, Mizzi S, et al. Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population. Cureus. 2020;12:e8195.10.7759/cureus.8195730271832572354
- 6. Tang Q, Lian Y, Yu J, et al. Anatomic mapping of molecular subtypes in diffuse glioma. BMC Neurology. 2017;17:183.10.1186/s12883-017-0961-8560293328915860
- 7. Yersal O. Clinical outcome of patients with glioblastoma multiforme: Single center experience. Journal of Oncological Sciences. 2017;3:123-126.10.1016/j.jons.2017.10.005
- 8. Li R, Chen X, You Y, et al. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics. Oncotarget. 2015;6:30968-30974.10.18632/oncotarget.5038474158126427041
- 9. Shah BK, Bista A, Sharma S. Survival Trends in Elderly Patients with Glioblastoma in the United States: a Population-based Study. Anticancer Res. 2016;36:4883-4886.10.21873/anticanres.1105227630344
- 10. Eriksson M, Kahari J, Vestman A, et al. Improved treatment of glioblastoma – changes in survival over two decades at a single regional Centre. Acta Oncol. 2019;58:334-341.10.1080/0284186X.2019.157127830732527
- 11. Yang W, Warrington NM, Taylor SJ, et al. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Sci Transl Med. 2019;11:eaao5253.10.1126/scitranslmed.aao5253650222430602536
- 12. Tian M, Ma W, Chen Y, et al. Impact of gender on the survival of patients with glioblastoma. Biosci Rep. 2018;38:BSR20180752.10.1042/BSR20180752623925530305382
- 13. Hansen S, Rasmussen BK, Laursen RJ, et al. Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry, 2009-2014. J Neurooncol. 2018;139:479-489.10.1007/s11060-018-2892-729754199
- 14. Behzadnia H, Alijani B, Emamhadi M, et al. Glioblastoma Multiforme: A Single Hospital Experience. Iran J Neurosurg. 2015;1:16-20.10.18869/acadpub.irjns.1.3.16
- 15. Korja M, Raj R, Seppä K, et al. Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland. Neuro Oncol. 2019;21:370-379.10.1093/neuonc/noy164638041630312433
- 16. Nizamutdinov D, Stock EM, Dandashi JA, et al. Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma. World Neurosurg. 2018;109:e67-e74.10.1016/j.wneu.2017.09.104572908628951270
- 17. Liang J, Lv X, Lu C, et al. Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas. BMC Cancer. 2020;20:35.10.1186/s12885-019-6511-6696138731941467